picropodophyllin has been researched along with Pituitary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, H; Jin, K; Mu, J; Pu, J; Ruan, L; Tan, S; Wang, F; Yang, G; Zhong, A | 1 |
Axelson, M; Girnita, A; Girnita, L; Hillman, J; Karström, A; Kratz, G; Larsson, O; Thoren, M; Ulfarsson, E; Vasilcanu, D; Yin, S | 1 |
2 other study(ies) available for picropodophyllin and Pituitary Neoplasms
Article | Year |
---|---|
Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
Topics: Adenylate Kinase; Adrenocorticotropic Hormone; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Corticotrophs; Humans; Metformin; Pituitary Neoplasms; Podophyllotoxin; Receptor, IGF Type 1; Signal Transduction | 2018 |
Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach.
Topics: Adolescent; Adult; Cell Proliferation; Child; Craniopharyngioma; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Inhibitory Concentration 50; Insulin-Like Growth Factor I; Middle Aged; Phosphorylation; Pituitary Neoplasms; Podophyllotoxin; Receptor, IGF Type 1; Tumor Cells, Cultured | 2005 |